These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21496535)

  • 1. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model.
    Meisel JA; Le HD; de Meijer VE; Nose V; Gura KM; Mulkern RV; Sharif MRA; Puder M
    J Pediatr Surg; 2011 Apr; 46(4):666-673. PubMed ID: 21496535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metabolomic analysis of two intravenous lipid emulsions in a murine model.
    Kalish BT; Le HD; Gura KM; Bistrian BR; Puder M
    PLoS One; 2013; 8(4):e59653. PubMed ID: 23565157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olive Oil and Soybean Oil Based Intravenous Lipid Emulsions, Liver Biochemistry and Clinical Outcomes.
    Araujo F; Fenton TR; Lukmanji S; Raman M
    Nutrients; 2018 May; 10(6):. PubMed ID: 29789518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study.
    Choudhary N; Tan K; Malhotra A
    Eur J Pediatr; 2018 May; 177(5):723-731. PubMed ID: 29445923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions.
    Lilja HE; Finkel Y; Paulsson M; Lucas S
    J Pediatr Surg; 2011 Jul; 46(7):1361-7. PubMed ID: 21763835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Index Use of Smoflipid in a Tertiary Intestinal Rehabilitation and Transplantation Program.
    Lam K; Schiano T; Fiel MI; Iyer K
    JPEN J Parenter Enteral Nutr; 2017 Nov; 41(1_suppl):20S-23S. PubMed ID: 29161210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral Soy Oil and Fish Oil Emulsions: Impact of Dose Restriction on Bile Flow and Brain Size of Parenteral Nutrition-Fed Neonatal Piglets.
    Josephson J; Turner JM; Field CJ; Wizzard PR; Nation PN; Sergi C; Ball RO; Pencharz PB; Wales PW
    JPEN J Parenter Enteral Nutr; 2015 Aug; 39(6):677-87. PubMed ID: 25326097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)--a double-blind, randomised, multicentre study in adults.
    Klek S; Chambrier C; Singer P; Rubin M; Bowling T; Staun M; Joly F; Rasmussen H; Strauss BJ; Wanten G; Smith R; Abraham A; Szczepanek K; Shaffer J
    Clin Nutr; 2013 Apr; 32(2):224-31. PubMed ID: 22796064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.
    Fallon EM; Le HD; Puder M
    Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions.
    Skouroliakou M; Konstantinou D; Agakidis C; Delikou N; Koutri K; Antoniadi M; Karagiozoglou-Lampoudi T
    Nutr Clin Pract; 2012 Dec; 27(6):817-24. PubMed ID: 22878361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
    Lee S; Park HJ; Yoon J; Hong SH; Oh CY; Lee SK; Seo JM
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):437-40. PubMed ID: 25560679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of changing the lipid component of home parenteral nutrition in adults.
    Osowska S; Kunecki M; Sobocki J; Tokarczyk J; Majewska K; Omidi M; Radkowski M; Fisk HL; Calder PC
    Clin Nutr; 2019 Jun; 38(3):1355-1361. PubMed ID: 29907355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.
    Pastor-Clerigues A; Marti-Bonmati E; Milara J; Almudever P; Cortijo J
    PLoS One; 2014; 9(12):e115404. PubMed ID: 25502575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil-based injectable lipid emulsions containing medium-chain triglycerides or added α-tocopherol offer anti-inflammatory benefits in a murine model of parenteral nutrition-induced liver injury.
    Baker MA; Cho BS; Anez-Bustillos L; Dao DT; Pan A; O'Loughlin AA; Lans ZM; Mitchell PD; Nosé V; Gura KM; Puder M; Fell GL
    Am J Clin Nutr; 2019 Apr; 109(4):1038-1050. PubMed ID: 30882140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.
    Ng K; Stoll B; Chacko S; Saenz de Pipaon M; Lauridsen C; Gray M; Squires EJ; Marini J; Zamora IJ; Olutoye OO; Burrin DG
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):656-71. PubMed ID: 25596209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Human Milk and Parenteral Lipid Emulsions on Serum Fatty Acid Profiles in Extremely Preterm Infants.
    Nilsson AK; Löfqvist C; Najm S; Hellgren G; Sävman K; Andersson MX; Smith LEH; Hellström A
    JPEN J Parenter Enteral Nutr; 2019 Jan; 43(1):152-161. PubMed ID: 29679529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic effects of two different lipid emulsions used in parenterally fed premature infants--a randomized comparative study.
    Demirel G; Oguz SS; Celik IH; Erdeve O; Uras N; Dilmen U
    Early Hum Dev; 2012 Jul; 88(7):499-501. PubMed ID: 22245235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosis.
    Cho BS; Fligor SC; Fell GL; Secor JD; Tsikis ST; Pan A; Yu LJ; Ko VH; Dao DT; Anez-Bustillos L; Hirsch TI; Lund J; Rustan AC; Fraser DA; Gura KM; Puder M
    PLoS One; 2023; 18(12):e0295244. PubMed ID: 38039287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.
    Vlaardingerbroek H; Ng K; Stoll B; Benight N; Chacko S; Kluijtmans LA; Kulik W; Squires EJ; Olutoye O; Schady D; Finegold ML; van Goudoever JB; Burrin DG
    J Lipid Res; 2014 Mar; 55(3):466-77. PubMed ID: 24478031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.